Get the Stockscreener App
4.93
2.18%
-0.11
After Hours:
4.97
0.04
+0.81%
Organogenesis Holdings Inc stock is traded at $4.93, with a volume of 731.15K.
It is down -2.18% in the last 24 hours and up +0.82% over the past month.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
See More
Previous Close:
$5.04
Open:
$5.04
24h Volume:
731.15K
Relative Volume:
0.89
Market Cap:
$625.41M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
138.10
EPS:
0.0357
Net Cash Flow:
$6.55M
1W Performance:
-1.40%
1M Performance:
+0.82%
6M Performance:
-6.27%
1Y Performance:
+88.89%
1-Day Range:
$4.89
$5.09
1-Week Range:
$4.745
$5.095
52-Week Range:
$2.6101
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Name
Organogenesis Holdings Inc
Sector
Phone
781-575-0775
Address
85 DAN ROAD, CANTON, MA
Compare ORGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.93 | 616.53M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Lake Street | Buy |
| Feb-07-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-15-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-24-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-10-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-10-20 | Initiated | SVB Leerink | Outperform |
| Aug-26-19 | Resumed | Credit Suisse | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
| Apr-17-19 | Initiated | Oppenheimer | Outperform |
| Apr-11-19 | Initiated | SunTrust | Buy |
View All
Organogenesis Holdings Inc Stock (ORGO) Latest News
What Fibonacci levels say about Organogenesis Holdings Inc. reboundWeekly Market Report & High Yield Stock Recommendations - Newser
How institutional ownership impacts Organogenesis Holdings Inc. stockShare Buyback & Step-by-Step Trade Execution Guides - Newser
Applying chart zones and confluence areas to Organogenesis Holdings Inc.2025 Historical Comparison & Risk Controlled Daily Plans - Newser
Using Ichimoku Cloud for Organogenesis Holdings Inc. technicals2025 Price Momentum & AI Enhanced Trading Alerts - Newser
visualizing organogenesis holdings inc. stock with heatmaps2025 Breakouts & Breakdowns & Verified Entry Point Detection - Newser
Will Organogenesis Holdings Inc. rebound enough to break evenShare Buyback & Consistent Income Trade Recommendations - Newser
Can technical indicators confirm Organogenesis Holdings Inc.’s reversalMarket Growth Review & Step-by-Step Trade Execution Guides - Newser
Institutional scanner results for Organogenesis Holdings Inc.July 2025 Action & Daily Profit Focused Stock Screening - Newser
Analyzing recovery setups for Organogenesis Holdings Inc. investorsRate Cut & Expert Curated Trade Setup Alerts - Newser
Is Organogenesis Holdings Inc. forming a bottoming baseJuly 2025 Rallies & Target Return Focused Stock Picks - Newser
Organogenesis Holdings Inc. stock outlook for YEARTrade Risk Assessment & Expert Approved Momentum Trade Ideas - Newser
Using flow based indicators on Organogenesis Holdings Inc.2025 Major Catalysts & Capital Protection Trading Alerts - Newser
Can momentum traders help lift Organogenesis Holdings Inc.Weekly Trade Report & Weekly Breakout Watchlists - Newser
Will Organogenesis Holdings Inc. see short term momentumInflation Watch & Safe Entry Point Identification - Newser
Is Organogenesis Holdings Inc. still worth holding after the dip2025 Buyback Activity & Consistent Profit Alerts - Newser
News impact scoring models applied to Organogenesis Holdings Inc.July 2025 Weekly Recap & Technical Pattern Based Buy Signals - Newser
Relative strength of Organogenesis Holdings Inc. in sector analysisJuly 2025 Analyst Calls & Long-Term Growth Stock Strategies - Newser
Trend analysis for Organogenesis Holdings Inc. this weekGlobal Markets & Proven Capital Preservation Tips - Newser
Visualizing Organogenesis Holdings Inc. stock with heatmapsMarket Activity Recap & Entry Point Confirmation Signals - Newser
What’s next for Organogenesis Holdings Inc. stock price2025 Key Lessons & Free Reliable Trade Execution Plans - Newser
Trexquant Investment LP Makes New $516,000 Investment in Organogenesis $ORGO - MarketBeat
How to escape a deep drawdown in Organogenesis Holdings Inc.Quarterly Profit Summary & Long-Term Capital Growth Ideas - Newser
Reversal indicators forming on Organogenesis Holdings Inc. stockBear Alert & Low Risk High Reward Trade Ideas - Newser
Advanced analytics toolkit walkthrough for Organogenesis Holdings Inc.Chart Signals & AI Optimized Trading Strategy Guides - Newser
Visual trend scoring systems applied to Organogenesis Holdings Inc.2025 Sector Review & Risk Adjusted Buy/Sell Alerts - Newser
Trexquant Investment LP Invests $516,000 in Organogenesis $ORGO - Defense World
Sector Leaders Rotate Capital Into Organogenesis Holdings Inc.Market Growth Review & Community Verified Swing Trade Signals - beatles.ru
Published on: 2025-09-08 18:24:21 - beatles.ru
Organogenesis Holdings Inc. Rebounds From Oversold Zone — Now What2025 Earnings Surprises & High Yield Stock Recommendations - beatles.ru
Global Skin Substitutes Market Set for Breakthrough Growth - openPR.com
Weekly Recap: Will Organogenesis Holdings Inc. outperform during market ralliesWeekly Trend Report & Free Long-Term Investment Growth Plans - 뉴스영
Nuveen LLC Acquires New Shares in Organogenesis $ORGO - MarketBeat
Technical analysis overview for Organogenesis Holdings Inc. stock2025 Market Outlook & Verified Momentum Stock Alerts - Newser
Backtesting results for Organogenesis Holdings Inc. trading strategiesQuarterly Risk Review & AI Based Buy and Sell Signals - Newser
Using R and stats models for Organogenesis Holdings Inc. forecastingQuarterly Trade Summary & Daily Price Action Insights - Newser
Will Organogenesis Holdings Inc. outperform during market ralliesWeekly Trade Recap & Safe Capital Growth Tips - خودرو بانک
American Century Companies Inc. Has $567,000 Holdings in Organogenesis $ORGO - Defense World
Russell Investments Group Ltd. Makes New $547,000 Investment in Organogenesis $ORGO - MarketBeat
Organogenesis Holdings Inc Stock (ORGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):